在儿科抑郁症中使用胺:系统性审查
Shakila Meshkat1, Joshua D Rosenblat2, Roger C Ho3
1Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.
Psychiatry research
|September 21, 2023
概括
胺在治疗儿科抑郁症方面表现有前途,显著减少了症状,几乎没有不良事件. 需要进一步的研究来证实它在儿童和青少年中的有效性和安全性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿科抑郁症是一种严重的疾病,患病率和死亡率很高.
- 胺,一种NMDA受体对抗剂,在成年人中表现出抗抑郁作用.
- 对于儿科抑郁症而言,胺的使用尚未得到充分证实.
研究的目的:
- 系统地审查有关胺治疗儿科抑郁症的疗效和安全性的现有文献.
- 确定当前研究中的差距,并建议未来的方向.
主要方法:
- 从创建到2022年6月,对电子数据库进行了系统审查.
- 纳入了6项研究,共有46名参与者 (平均年龄15.7岁).
- 研究包括病例报告,随机临床试验和开放试验,主要使用静脉注射胺 (0.5 mg/kg).
主要成果:
- 胺与抑郁症状的显著减少有关.
- 没有报告严重的不良事件.
- 审查的研究表明胺在儿科抑郁症治疗中的潜在作用.
结论:
- 胺可能是对儿科抑郁症的可行的治疗选择.
- 限制包括小样本大小和仅使用静脉注射.
- 需要进行更大规模的研究,采用多种不同的施用方法,以确认疗效和安全性.
相关概念视频
Parenteral Anesthetics: Overview
151
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
151
Electroconvulsive Therapy
59
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
59
Sedatives and Hypnotics Drugs: Miscellaneous Agents
196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196


